Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
10.18
-0.10 (-0.97%)
Oct 6, 2025, 4:00 PM EDT - Market closed
Telix Pharmaceuticals Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$21.00
Upside
+106.29%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $23 → $20 | Strong Buy | Maintains | $23 → $20 | +96.46% | Sep 23, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +116.11% | Sep 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $23 → $20 | Strong Buy | Maintains | $23 → $20 | +96.46% | Sep 10, 2025 |
| Wedbush | Wedbush | Buy Reiterates $22 | Buy | Reiterates | $22 | +116.11% | Aug 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +125.93% | Jul 3, 2025 |
| Wedbush | Wedbush | Buy Reiterates $22 | Buy | Reiterates | $22 | +116.11% | Jun 12, 2025 |
| Wedbush | Wedbush | Buy Initiates $22 | Buy | Initiates | $22 | +116.11% | Jun 5, 2025 |
| UBS | UBS | Strong Buy Maintains $21 → $22 | Strong Buy | Maintains | $21 → $22 | +116.11% | Jan 27, 2025 |
| UBS | UBS | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +106.29% | Nov 15, 2024 |